✦ LIBER ✦

Severe cholestasis related to itraconazole for the treatment of onychomycosis

✍ Scribed by Jayant A Talwalkar; Roy E Soetikno; David L Carr-Locke; Carl L Berg

Book ID: 119396806
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 33 KB
Volume: 94
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(99)00682-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Itraconazole Oral Solution for the Treat

Itraconazole Oral Solution for the Treatment of Onychomycosis

✍ Aditya K. Gupta; Paul Adam; Sophie L. R. Hofstader 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

A novel itraconazole tablet for the trea

A novel itraconazole tablet for the treatment of onychomycosis

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Clinical and pharmacokinetic investigati

Clinical and pharmacokinetic investigation of continuous itraconazole for the treatment of onychomycosis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Itraconazole versus terbinafine (LAMISIL

Itraconazole versus terbinafine (LAMISIL®): which is better for the treatment of onychomycosis?

✍ J.F Honeyman; Filho S Talarico; L.H.F Arruda; A.C Pereira Jr; J.R Santamarı́a; E 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

SAFETY AND EFFICACY OF ITRACONAZOLE FOR

SAFETY AND EFFICACY OF ITRACONAZOLE FOR THE TREATMENT OF ONYCHOMYCOSIS IN THE DIABETIC POPULATION

✍ Won-Young Chey; Young-Gull Kim; Eui-Chang Chung; Ai-Young Lee 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Continuous and intermittent itraconazole

Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison

✍ HAVU; BRANDT; HEIKKILÄ; HOLLMEN; OKSMAN; RANTANEN; SAARI; STUBB; TURJANMAA; PIEP 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

This multicentre, double-blind, randomized study compared the pharmacokinetics of itraconazole given at 200 mg once daily for 3 months and intermittently at 200 mg twice daily for 1 week per month followed by a 3-week drug-free period for 3 months in the treatment of onychomycosis. Patients were fol